DIAGNOS (ADK.V) Stock Analysis & Winston Score

DIAGNOS Inc. is a small Canadian healthcare technology company that uses artificial intelligence to help detect eye diseases early. Its main product, called CARA, analyzes images of the back of the eye to screen for conditions like diabetic retinopathy, which can cause blindness if not caught in time. The company sells its services to healthcare providers, clinics, and public health programs, primarily in Canada and select international markets. DIAGNOS makes money by charging fees when its AI software analyzes eye scans, rather than selling hardware. It is a very small company, and its deeply negative margins show it is spending far more than it earns right now. The company's main competitive angle is its specialized AI trained on a large database of retinal images, but it faces stiff competition from larger medical imaging and AI firms with much greater resources. The key risk is whether it can grow its customer base fast enough to reach profitability before running out of funding.